- Home
- ROOT vs AMRX Comparison
ROOT vs AMRX Comparison
Compare ROOT & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROOT
- AMRX
- Stock Information
- Founded
- ROOT 2015
- AMRX 2002
- Country
- ROOT United States
- AMRX United States
- Employees
- ROOT N/A
- AMRX N/A
- Industry
- ROOT Property-Casualty Insurers
- AMRX Biotechnology: Pharmaceutical Preparations
- Sector
- ROOT Finance
- AMRX Health Care
- Exchange
- ROOT Nasdaq
- AMRX Nasdaq
- Market Cap
- ROOT 2.3B
- AMRX 2.5B
- IPO Year
- ROOT 2020
- AMRX N/A
- Fundamental
- Price
- ROOT $127.30
- AMRX $8.32
- Analyst Decision
- ROOT Buy
- AMRX Strong Buy
- Analyst Count
- ROOT 6
- AMRX 4
- Target Price
- ROOT $134.80
- AMRX $11.50
- AVG Volume (30 Days)
- ROOT 457.1K
- AMRX 1.8M
- Earning Date
- ROOT 08-06-2025
- AMRX 08-08-2025
- Dividend Yield
- ROOT N/A
- AMRX N/A
- EPS Growth
- ROOT N/A
- AMRX N/A
- EPS
- ROOT 3.16
- AMRX N/A
- Revenue
- ROOT $1,271,000,000.00
- AMRX $2,830,186,000.00
- Revenue This Year
- ROOT $22.06
- AMRX $9.84
- Revenue Next Year
- ROOT $10.86
- AMRX $7.33
- P/E Ratio
- ROOT $40.51
- AMRX N/A
- Revenue Growth
- ROOT 98.66
- AMRX 13.42
- 52 Week Low
- ROOT $34.04
- AMRX $6.32
- 52 Week High
- ROOT $181.14
- AMRX $9.48
- Technical
- Relative Strength Index (RSI)
- ROOT 42.79
- AMRX 61.71
- Support Level
- ROOT $121.41
- AMRX $8.05
- Resistance Level
- ROOT $130.33
- AMRX $8.24
- Average True Range (ATR)
- ROOT 7.94
- AMRX 0.21
- MACD
- ROOT -1.76
- AMRX 0.03
- Stochastic Oscillator
- ROOT 16.55
- AMRX 90.91
About ROOT Root Inc.
Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. It generates revenue from the sales of auto insurance policies within the United States.
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.